{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:25:47Z","timestamp":1791069947619,"version":"4.1.0"},"reference-count":165,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.00081","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T04:15:47Z","timestamp":1551240947000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases"],"prefix":"10.3389","volume":"9","author":[{"given":"Kwai Fung","family":"Hui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Pei Tung","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam Pui","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Kwok Shing","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-319-22822-8_1","article-title":"Why and how Epstein-Barr virus was discovered 50 years ago","volume":"390","author":"Epstein","year":"2015","journal-title":"Curr Top Microbiol Immunol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32049","article-title":"High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma","author":"Hui","year":"2018","journal-title":"Int J Cancer"},{"key":"B3","first-page":"2575","volume-title":"Epstein-Barr Virus","author":"Rickinson","year":"2001"},{"key":"B4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1073\/pnas.2237267100","article-title":"Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo","volume":"101","author":"Hochberg","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1128\/JVI.03003-12","article-title":"Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature","volume":"87","author":"Kelly","year":"2013","journal-title":"J Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.semcancer.2009.07.004","article-title":"Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology","volume":"19","author":"Rowe","year":"2009","journal-title":"Semin Cancer Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","article-title":"EBV-associated lymphoproliferative disorders: classification and treatment","volume":"13","author":"Carbone","year":"2008","journal-title":"Oncologist"},{"key":"B8","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1128\/JVI.65.5.2237-2244.1991","article-title":"Pathways of activation of the Epstein-Barr virus productive cycle","volume":"65","author":"Sinclair","year":"1991","journal-title":"J Virol."},{"key":"B9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1128\/JVI.69.2.983-993.1995","article-title":"Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs","volume":"69","author":"Robertson","year":"1995","journal-title":"J Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"10282","DOI":"10.1128\/JVI.76.20.10282-10289.2002","article-title":"Promoter sequences required for reactivation of Epstein-Barr virus from latency","volume":"76","author":"Binne","year":"2002","journal-title":"J Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1002\/ijc.24945","article-title":"Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death","volume":"126","author":"Hui","year":"2010","journal-title":"Int J Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9680","DOI":"10.1128\/JVI.01001-07","article-title":"Unique signaling properties of CTAR1 in LMP1-mediated transformation","volume":"81","author":"Mainou","year":"2007","journal-title":"J Virol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1128\/JVI.63.12.4998-5005.1989","article-title":"Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells","volume":"63","author":"Haddad","year":"1989","journal-title":"J Virol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1128\/JVI.72.7.5559-5564.1998","article-title":"The Epstein-Barr virus (EBV) gN homolog BLRF1 encodes a 15-kilodalton glycoprotein that cannot be authentically processed unless it is coexpressed with the EBV gM homolog BBRF3","volume":"72","author":"Lake","year":"1998","journal-title":"J Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/sj.cdd.4401912","article-title":"Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4","volume":"13","author":"Marine","year":"2006","journal-title":"Cell Death Differ."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/rmv.441","article-title":"Latent and lytic Epstein-Barr virus replication strategies","volume":"15","author":"Tsurumi","year":"2005","journal-title":"Rev Med Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2567.2011.03476.x","article-title":"Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins","volume":"134","author":"Ning","year":"2011","journal-title":"Immunology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.1128\/jvi.00239-09","article-title":"Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ T cells correlates with increased resistance to galectin-1-mediated suppression","volume":"83","author":"Smith","year":"2009","journal-title":"J Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3389\/fmicb.2018.00416","article-title":"Emergence of CD4+ and CD8+ polyfunctional T cell responses against immunodominant lytic and latent EBV antigens in children with primary EBV infection","volume":"9","author":"Lam","year":"2018","journal-title":"Front Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1182\/blood-2014-01-553024","article-title":"Role for early-differentiated natural killer cells in infectious mononucleosis","volume":"124","author":"Azzi","year":"2014","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3389\/fimmu.2016.00607","article-title":"NKG2A-expressing natural killer cells dominate the response to autologous lymphoblastoid cells infected with Epstein-Barr virus","volume":"7","author":"Hatton","year":"2016","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/JVI.68.6.3491-3498.1994","article-title":"Epstein-Barr virus nuclear antigen EBNA3C\/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells","volume":"68","author":"Allday","year":"1994","journal-title":"J Virol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1073\/pnas.0813237106","article-title":"Regulation of Cyclin A protein in meiosis and early embryogenesis","volume":"106","author":"Vardy","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/j.1460-2075.1992.tb05135.x","article-title":"Cyclin A is required at two points in the human cell cycle","volume":"11","author":"Pagano","year":"1992","journal-title":"EMBO J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"18562","DOI":"10.1073\/pnas.0503886102","article-title":"Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase","volume":"102","author":"Knight","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1073\/pnas.0801053105","article-title":"EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes","volume":"105","author":"Kashuba","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1004304","DOI":"10.1371\/journal.ppat.1004304","article-title":"EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation","volume":"10","author":"Banerjee","year":"2014","journal-title":"PLoS Pathog."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1128\/MCB.25.5.1749-1763.2005","article-title":"SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen","volume":"25","author":"Knight","year":"2005","journal-title":"Mol Cell Biol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006500","article-title":"An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation","volume":"13","author":"Pei","year":"2017","journal-title":"PLoS Pathog."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1073\/pnas.1019599108","article-title":"Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression","volume":"108","author":"Maruo","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1000951","DOI":"10.1371\/journal.ppat.1000951","article-title":"Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP","volume":"6","author":"Skalska","year":"2010","journal-title":"PLoS Pathog."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1003187","DOI":"10.1371\/journal.ppat.1003187","article-title":"Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines","volume":"9","author":"Skalska","year":"2013","journal-title":"PLoS Pathog."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/sj.onc.1207253","article-title":"The EBNA-3 gene family proteins disrupt the G2\/M checkpoint","volume":"23","author":"Krauer","year":"2004","journal-title":"Oncogene"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.1128\/JVI.00053-07","article-title":"The ATM\/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2\/M cell cycle block","volume":"81","author":"Choudhuri","year":"2007","journal-title":"J Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1128\/MCB.20.4.1344-1360.2000","article-title":"Epstein-Barr virus suppresses a G(2)\/M checkpoint activated by genotoxins","volume":"20","author":"Wade","year":"2000","journal-title":"Mol Cell Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/sj.onc.1203327","article-title":"Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis","volume":"19","author":"Parker","year":"2000","journal-title":"Oncogene"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e13979","DOI":"10.1371\/journal.pone.0013979","article-title":"Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification","volume":"5","author":"White","year":"2010","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.molimm.2010.02.017","article-title":"Transactivators Zta and Rta of Epstein-Barr virus promote G0\/G1 to S transition in Raji cells: a novel relationship between lytic virus and cell cycle","volume":"47","author":"Guo","year":"2010","journal-title":"Mol Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1128\/JVI.78.9.4847-4865.2004","article-title":"CCAAT\/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle","volume":"78","author":"Wu","year":"2004","journal-title":"J Virol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1099\/vir.0.034405-0","article-title":"Epstein-Barr virus Rta-mediated transactivation of p21 and 14-3-3sigma arrests cells at the G1\/S transition by reducing cyclin E\/CDK2 activity","volume":"93","author":"Huang","year":"2012","journal-title":"J Gen Virol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1128\/JVI.78.1.104-115.2004","article-title":"Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication","volume":"78","author":"Kudoh","year":"2004","journal-title":"J Virol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"10030","DOI":"10.1128\/JVI.76.19.10030-10037.2002","article-title":"The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block","volume":"76","author":"Mauser","year":"2002","journal-title":"J Virol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1128\/JVI.75.10.4482-4489.2001","article-title":"Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents","volume":"75","author":"Rodriguez","year":"2001","journal-title":"J Virol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ijc.29698","article-title":"Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir","volume":"138","author":"Hui","year":"2016","journal-title":"Int J Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"29987","DOI":"10.1074\/jbc.M303977200","article-title":"Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP\/USP7","volume":"278","author":"Holowaty","year":"2003","journal-title":"J Biol Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.4049\/jimmunol.0803218","article-title":"Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation","volume":"182","author":"Horst","year":"2009","journal-title":"J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1099\/vir.0.83414-0","article-title":"Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones","volume":"89","author":"Young","year":"2008","journal-title":"J Gen Virol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"228","DOI":"10.18632\/oncotarget.443","article-title":"Regulation of p53: a collaboration between Mdm2 and Mdmx","volume":"3","author":"Pei","year":"2012","journal-title":"Oncotarget"},{"key":"B51","doi-asserted-by":"publisher","first-page":"672","DOI":"10.7150\/ijbs.4283","article-title":"Surf the post-translational modification network of p53 regulation","volume":"8","author":"Gu","year":"2012","journal-title":"Int J Biol Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.virol.2009.03.027","article-title":"Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities","volume":"388","author":"Yi","year":"2009","journal-title":"Virology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e1002573","DOI":"10.1371\/journal.ppat.1002573","article-title":"E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells","volume":"8","author":"Saha","year":"2012","journal-title":"PLoS Pathog."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1128\/jvi.02408-08","article-title":"Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2","volume":"83","author":"Saha","year":"2009","journal-title":"J Virol."},{"key":"B55","first-page":"2523","article-title":"Immunochemical analysis of the interaction of p53 with MDM2;\u2013fine mapping of the MDM2 binding site on p53 using synthetic peptides","volume":"9","author":"Picksley","year":"1994","journal-title":"Oncogene"},{"key":"B56","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/387296a0.","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/sj.onc.1210668","article-title":"Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma","volume":"27","author":"Anderton","year":"2008","journal-title":"Oncogene"},{"key":"B58","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1093\/nar\/gks391","article-title":"BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV","volume":"40","author":"Paschos","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"13984","DOI":"10.1128\/JVI.79.22.13984-13992.2005","article-title":"Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines","volume":"79","author":"Hong","year":"2005","journal-title":"J Virol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/08880010601094102","article-title":"Control of bleeding associated with hemophagocytic syndrome in children: an audit of the clinical use of recombinant activated factor VII","volume":"24","author":"Celkan","year":"2007","journal-title":"Pediatr Hematol Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"8583","DOI":"10.18632\/oncotarget.2323","article-title":"Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma","volume":"5","author":"Chiu","year":"2014","journal-title":"Oncotarget"},{"key":"B63","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.chom.2011.08.013","article-title":"Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication","volume":"10","author":"Li","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1093\/nar\/gkp1169","article-title":"Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells","volume":"38","author":"Wu","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.virusres.2013.01.016","article-title":"Cellular localization of BARF1 oncoprotein and its cell stimulating activity in human epithelial cell","volume":"174","author":"Sakka","year":"2013","journal-title":"Virus Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","article-title":"Inhibition of ubiquitin\/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1","volume":"94","author":"Levitskaya","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.7150\/ijbs.16564","article-title":"Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis","volume":"12","author":"Li","year":"2016","journal-title":"Int J Biol Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ab.2006.04.011","article-title":"Sub-attomole oligonucleotide and p53 cDNA determinations via a high-resolution surface plasmon resonance combined with oligonucleotide-capped gold nanoparticle signal amplification","volume":"354","author":"Yao","year":"2006","journal-title":"Anal Biochem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e1002704","DOI":"10.1371\/journal.ppat.1002704","article-title":"The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination","volume":"8","author":"Jochum","year":"2012","journal-title":"PLoS Pathog."},{"key":"B70","first-page":"1711","article-title":"The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes","volume":"11","author":"Stuart","year":"1995","journal-title":"Oncogene"},{"key":"B71","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1128\/jvi.02183-15","article-title":"The missing link in Epstein-Barr virus immune evasion: the BDLF3 gene induces ubiquitination and downregulation of major histocompatibility complex class I (MHC-I) and MHC-II","volume":"90","author":"Quinn","year":"2015","journal-title":"J Virol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/nm1296-1379","article-title":"Epstein-Barr virus-driven gene therapy for EBV-related lymphomas","volume":"2","author":"Franken","year":"1996","journal-title":"Nat Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/1097-0215(20000815)87:4<606::AID-IJC23>3.0.CO;2-O","article-title":"Efficacy of ionizing radiation combined with adenoviral p53 therapy in EBV-positive nasopharyngeal carcinoma","volume":"87","author":"Li","year":"2000","journal-title":"Int J Cancer"},{"key":"B74","first-page":"171","article-title":"Tumor-targeted gene therapy for nasopharyngeal carcinoma","volume":"62","author":"Li","year":"2002","journal-title":"Cancer Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nm1704","article-title":"Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses","volume":"14","author":"Lasaro","year":"2008","journal-title":"Nat Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e1273311","DOI":"10.1080\/2162402X.2016.1273311","article-title":"Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: phenotype and effector function of T cells impact on clinical response","volume":"6","author":"Smith","year":"2017","journal-title":"Oncoimmunology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"E204","DOI":"10.3390\/cancers10060204","article-title":"The role of immune checkpoint inhibitors in classical Hodgkin lymphoma","volume":"10","author":"Meti","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1007\/s00277-018-3467-6","article-title":"Persistent peripheral blood EBV-DNA positive with high expression of PD-L1 and upregulation of CD4+ CD25+ T cell ratio in early stage NK\/T cell lymphoma patients may predict worse outcome","volume":"97","author":"Li","year":"2018","journal-title":"Ann Hematol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/cr.2016.153","article-title":"Immunotherapy against cancer-related viruses","volume":"27","author":"Tashiro","year":"2017","journal-title":"Cell Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"19255","DOI":"10.18632\/oncotarget.13770","article-title":"Novel Epstein-Barr virus-like particles incorporating gH\/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice","volume":"8","author":"Perez","year":"2017","journal-title":"Oncotarget"},{"key":"B82","doi-asserted-by":"crossref","first-page":"7654","DOI":"10.1128\/JVI.67.12.7654-7658.1993","article-title":"Epstein-Barr virus induces fragmentation of chromosomal DNA during lytic infection","volume":"67","author":"Kawanishi","year":"1993","journal-title":"J Virol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1158\/0008-5472.CAN-06-1006","article-title":"Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression","volume":"66","author":"Feng","year":"2006","journal-title":"Cancer Res."},{"key":"B84","doi-asserted-by":"crossref","first-page":"9029","DOI":"10.1128\/JVI.73.11.9029-9038.1999","article-title":"Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta","volume":"73","author":"Rodriguez","year":"1999","journal-title":"J Virol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/ni0709-669","article-title":"NKT cells turn ten","volume":"10","author":"Burrows","year":"2009","journal-title":"Nat Immunol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4161\/cc.8.1.7411","article-title":"The Epstein-Barr virus replication and transcription activator, Rta\/BRLF1, induces cellular senescence in epithelial cells","volume":"8","author":"Chen","year":"2009","journal-title":"Cell Cycle"},{"key":"B87","doi-asserted-by":"publisher","first-page":"9175","DOI":"10.1128\/JVI.00309-12","article-title":"The \u201cBridge\u201d in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection","volume":"86","author":"Horst","year":"2012","journal-title":"J Virol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/ijc.27439","article-title":"Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma","volume":"131","author":"Hui","year":"2012","journal-title":"Int J Cancer"},{"key":"B89","first-page":"1920","article-title":"Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors","volume":"62","author":"Feng","year":"2002","journal-title":"Cancer Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1128\/JVI.78.4.1893-1902.2004","article-title":"Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas","volume":"78","author":"Feng","year":"2004","journal-title":"J Virol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1099\/vir.0.019729-0","article-title":"Characterization of Epstein-Barr virus BGLF4 kinase expression control at the transcriptional and translational levels","volume":"91","author":"Wang","year":"2010","journal-title":"J Gen Virol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/nm.1864","article-title":"Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors","volume":"14","author":"Fu","year":"2008","journal-title":"Nat Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1158\/1078-0432.CCR-12-0574","article-title":"Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors","volume":"18","author":"Wildeman","year":"2012","journal-title":"Clin Cancer Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00432-015-1969-3","article-title":"Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma","volume":"141","author":"Stoker","year":"2015","journal-title":"J Cancer Res Clin Oncol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"0042","DOI":"10.1038\/s41551-017-0042","article-title":"EBNA1-targeted probe for the imaging and growth inhibition of tumours associated with the Epstein\u2013Barr virus","volume":"1","author":"Jiang","year":"2017","journal-title":"Nat Biomed Eng."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010126","article-title":"Discovery of selective inhibitors against EBNA1 via high throughput in silico virtual screening","volume":"5","author":"Li","year":"2010","journal-title":"PLoS ONE"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1177\/1087057110379154","article-title":"Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1","volume":"15","author":"Thompson","year":"2010","journal-title":"J Biomol Screen."},{"key":"B98","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1038\/s41388-018-0147-x","article-title":"Lymphomas driven by Epstein\u2013Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2","volume":"37","author":"AlQarni","year":"2018","journal-title":"Oncogene"},{"key":"B99","doi-asserted-by":"publisher","first-page":"36573","DOI":"10.1074\/jbc.M802968200","article-title":"Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos","volume":"283","author":"Vaysberg","year":"2008","journal-title":"J Biol Chem."},{"key":"B100","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2217\/fon.09.53","article-title":"Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma","volume":"5","author":"Morris","year":"2009","journal-title":"Future Oncol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/bjh.13089","article-title":"Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines","volume":"167","author":"Hui","year":"2014","journal-title":"Br J Haematol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1158\/1535-7163.MCT-12-0811","article-title":"Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus","volume":"12","author":"Hui","year":"2013","journal-title":"Mol Cancer Ther."},{"key":"B103","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.antiviral.2012.05.003","article-title":"Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A","volume":"95","author":"Dargart","year":"2012","journal-title":"Antiviral Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1158\/1535-7163.Mct-10-0833","article-title":"Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma","volume":"10","author":"Cen","year":"2011","journal-title":"Mol Cancer Ther."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1182\/blood-2017-07-796821","article-title":"EBV latent membrane protein 2A orchestrates p27(kip1) degradation via Cks1 to accelerate MYC-driven lymphoma in mice","volume":"130","author":"Fish","year":"2017","journal-title":"Blood"},{"key":"B106","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1128\/JVI.01096-06","article-title":"Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells","volume":"81","author":"Leao","year":"2007","journal-title":"J Virol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"10709","DOI":"10.1128\/JVI.79.16.10709-10717.2005","article-title":"Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A,\u22123B, and\u22123C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis","volume":"79","author":"Kelly","year":"2005","journal-title":"J Virol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"25101","DOI":"10.18632\/oncotarget.25341","article-title":"Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib","volume":"9","author":"Hui","year":"2018","journal-title":"Oncotarget"},{"key":"B109","doi-asserted-by":"publisher","first-page":"31018","DOI":"10.18632\/oncotarget.5041","article-title":"Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"B110","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1182\/blood-2011-04-347112","article-title":"Endoplasmic reticulum stress causes EBV lytic replication","volume":"118","author":"Taylor","year":"2011","journal-title":"Blood"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.bbi.2010.04.013","article-title":"Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression","volume":"24","author":"Yang","year":"2010","journal-title":"Brain Behav Immun."},{"key":"B112","doi-asserted-by":"publisher","first-page":"e1006249","DOI":"10.1371\/journal.ppat.1006249","article-title":"Chloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1\/TRIM28 in Burkitt lymphoma cells","volume":"13","author":"Li","year":"2017","journal-title":"PLoS Pathog."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1099\/vir.0.058040-0","article-title":"Microtubule depolymerization activates the Epstein-Barr virus lytic cycle through protein kinase C pathways in nasopharyngeal carcinoma cells","volume":"94","author":"Liu","year":"2013","journal-title":"J Gen Virol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"e1006404","DOI":"10.1371\/journal.ppat.1006404","article-title":"Hypoxia-inducible factor-1alpha plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter","volume":"13","author":"Kraus","year":"2017","journal-title":"PLoS Pathog."},{"key":"B115","doi-asserted-by":"publisher","first-page":"e84919","DOI":"10.1371\/journal.pone.0084919","article-title":"Reactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N\u2032-nitro-N-nitrosoguanidine","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS ONE"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.bbamcr.2015.03.011","article-title":"PKC theta and p38 MAPK activate the EBV lytic cycle through autophagy induction","volume":"1853","author":"Gonnella","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/jnci\/djh313","article-title":"Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas","volume":"96","author":"Feng","year":"2004","journal-title":"J Natl Cancer Inst."},{"key":"B118","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1158\/1078-0432.CCR-15-2242","article-title":"Lenalidomide, thalidomide, and pomalidomide reactivate the Epstein-Barr virus lytic cycle through phosphoinositide 3-kinase signaling and Ikaros expression","volume":"22","author":"Jones","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"12133","DOI":"10.1128\/JVI.02033-14","article-title":"Regulation of autophagic activation by Rta of Epstein-Barr virus via the extracellular signal-regulated kinase pathway","volume":"88","author":"Hung","year":"2014","journal-title":"J Virol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"e1876","DOI":"10.1038\/cddis.2015.156","article-title":"Inhibition of autophagy in EBV-positive Burkitt's lymphoma cells enhances EBV lytic genes expression and replication","volume":"6","author":"De Leo","year":"2015","journal-title":"Cell Death Dis."},{"key":"B121","doi-asserted-by":"publisher","first-page":"12715","DOI":"10.1128\/JVI.02199-14","article-title":"Epstein-barr virus blocks the autophagic flux and appropriates the autophagic machinery to enhance viral replication","volume":"88","author":"Granato","year":"2014","journal-title":"J Virol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e1000506","DOI":"10.1371\/journal.ppat.1000506","article-title":"Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes","volume":"5","author":"Hertle","year":"2009","journal-title":"PLoS Pathog."},{"key":"B123","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2217\/fmb.12.147","article-title":"Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis","volume":"8","author":"Saha","year":"2013","journal-title":"Fut Microbiol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"19500","DOI":"10.1073\/pnas.0604919104","article-title":"Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells","volume":"103","author":"Maruo","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B125","first-page":"962","article-title":"Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase","volume":"7","author":"Butler","year":"2001","journal-title":"Clin Cancer Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"e102684","DOI":"10.1371\/journal.pone.0102684","article-title":"Selective HDAC inhibition for the disruption of latent HIV-1 infection","volume":"9","author":"Barton","year":"2014","journal-title":"PLoS ONE"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1128\/JVI.02665-13","article-title":"Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation","volume":"88","author":"Shin","year":"2014","journal-title":"J Virol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"e1005142","DOI":"10.1371\/journal.ppat.1005142","article-title":"The depsipeptide romidepsin reverses HIV-1 latency in vivo","volume":"11","author":"Sogaard","year":"2015","journal-title":"PLoS Pathog."},{"key":"B129","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2217\/epi.12.52","article-title":"A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin [depsipeptide, Istodax(R)]","volume":"4","author":"Harrison","year":"2012","journal-title":"Epigenomics"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1371\/journal.ppat.0030065","article-title":"Identification of cellular genes targeted by KSHV-encoded microRNAs","volume":"3","author":"Samols","year":"2007","journal-title":"PLoS Pathog."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1128\/JVI.02021-06","article-title":"Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression","volume":"81","author":"Radziewicz","year":"2007","journal-title":"J Virol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1158\/1078-0432.CCR-09-0966","article-title":"Persuading natural killer cells to eliminate bad B cells","volume":"15","author":"Cooper","year":"2009","journal-title":"Clin Cancer Res."},{"key":"B133","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/JVI.74.2.710-720.2000","article-title":"Histone acetylation and reactivation of Epstein-Barr virus from latency","volume":"74","author":"Jenkins","year":"2000","journal-title":"J Virol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1128\/JVI.00116-08","article-title":"Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors","volume":"82","author":"Countryman","year":"2008","journal-title":"J Virol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1002\/ijc.28924","article-title":"Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism","volume":"135","author":"Hui","year":"2014","journal-title":"Int J Cancer"},{"key":"B136","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.V100.5.1755.h81702001755_1755_1764","article-title":"B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells","volume":"100","author":"Moosmann","year":"2002","journal-title":"Blood"},{"key":"B137","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/1521-4141(200103)31:3<708::AID-IMMU708>3.0.CO;2-5","article-title":"Frequent recognition of BCRF1, a late lytic cycle protein of Epstein-Barr virus, in the HLA-B*2705 context: evidence for a TAP-independent processing","volume":"31","author":"Saulquin","year":"2001","journal-title":"Eur J Immunol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1182\/blood.V97.3.700","article-title":"The flow cytometric analysis of telomere length in antigen-specific CD8+ T cells during acute Epstein-Barr virus infection","volume":"97","author":"Plunkett","year":"2001","journal-title":"Blood"},{"key":"B139","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"Induction, function and regulation of IL-17-producing T cells","volume":"38","author":"Mills","year":"2008","journal-title":"Eur J Immunol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nri2451","article-title":"Harnessing invariant NKT cells in vaccination strategies","volume":"9","author":"Cerundolo","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2119\/molmed.2009.00035","article-title":"Regulatory NK-cell functions in inflammation and autoimmunity","volume":"15","author":"Lunemann","year":"2009","journal-title":"Mol Med."},{"key":"B142","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1128\/MCB.21.17.5979-5991.2001","article-title":"Regulation of transcription factor YY1 by acetylation and deacetylation","volume":"21","author":"Yao","year":"2001","journal-title":"Mol Cell Biol."},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/v9110352","article-title":"Therapeutic strategies against Epstein-Barr Virus-associated cancers using proteasome inhibitors","volume":"9","author":"Hui","year":"2017","journal-title":"Viruses"},{"key":"B144","doi-asserted-by":"publisher","first-page":"e925","DOI":"10.1038\/cddis.2013.440","article-title":"Bortezomib antagonizes microtubule-interfering drug-induced apoptosis by inhibiting G2\/M transition and MCL-1 degradation","volume":"4","author":"Rapino","year":"2013","journal-title":"Cell Death Dis."},{"key":"B145","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3892\/ijo.2012.1448.","article-title":"Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1","volume":"41","author":"Hong","year":"2012","journal-title":"Int J Oncol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/sj.leu.2404528","article-title":"Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma","volume":"21","author":"Bonvini","year":"2007","journal-title":"Leukemia"},{"key":"B147","doi-asserted-by":"publisher","first-page":"e1002418","DOI":"10.1371\/journal.ppat.1002418","article-title":"Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis","volume":"7","author":"Cai","year":"2011","journal-title":"PLoS Pathog."},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004415","article-title":"Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1\/CIP1","volume":"10","author":"Tursiella","year":"2014","journal-title":"PLoS Pathog."},{"key":"B149","doi-asserted-by":"publisher","first-page":"10029","DOI":"10.1128\/JVI.02241-06","article-title":"Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells","volume":"81","author":"Zou","year":"2007","journal-title":"J Virol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1182\/blood-2011-01-332379","article-title":"Bortezomib induction of C\/EBPbeta mediates Epstein-Barr virus lytic activation in Burkitt lymphoma","volume":"117","author":"Shirley","year":"2011","journal-title":"Blood"},{"key":"B151","doi-asserted-by":"publisher","first-page":"13052","DOI":"10.1038\/s41598-017-13533-7","article-title":"Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagy","volume":"7","author":"Granato","year":"2017","journal-title":"Sci Rep."},{"key":"B152","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.18632\/oncotarget.6601","article-title":"Induction of MAPK- and ROS-dependent autophagy and apoptosis in gastric carcinoma by combination of romidepsin and bortezomib","volume":"7","author":"Hui","year":"2016","journal-title":"Oncotarget"},{"key":"B153","doi-asserted-by":"publisher","first-page":"13360","DOI":"10.1128\/JVI.01850-12","article-title":"The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli","volume":"86","author":"Hagemeier","year":"2012","journal-title":"J Virol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"E505","DOI":"10.3390\/cancers10120505","article-title":"Intracellular iron chelation by a novel compound, C7, reactivates Epstein(-)Barr virus (EBV) lytic cycle via the ERK-autophagy axis in EBV-positive epithelial cancers","volume":"10","author":"Yiu","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B155","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1080\/15548627.2015.1115939","article-title":"Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations","volume":"11","author":"Pujals","year":"2015","journal-title":"Autophagy"},{"key":"B156","doi-asserted-by":"publisher","first-page":"9700","DOI":"10.1093\/nar\/gku697","article-title":"Epstein-Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1","volume":"42","author":"Bazot","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B157","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1128\/JVI.77.7.4261-4272.2003","article-title":"Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines","volume":"77","author":"Knight","year":"2003","journal-title":"J Virol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1073\/pnas.2237183100","article-title":"Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK\/IKK alpha-dependent noncanonical NF-kappaB activation","volume":"101","author":"Luftig","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B159","doi-asserted-by":"publisher","first-page":"51134","DOI":"10.1074\/jbc.M304771200","article-title":"Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52","volume":"278","author":"Atkinson","year":"2003","journal-title":"J Biol Chem."},{"key":"B160","doi-asserted-by":"publisher","first-page":"e01918","DOI":"10.1128\/JVI.01918-17","article-title":"Epstein-Barr virus (EBV) latent protein EBNA3A directly targets and silences the STK39 gene in B cells infected by EBV","volume":"92","author":"Bazot","year":"2018","journal-title":"J Virol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"e1000492","DOI":"10.1371\/journal.ppat.1000492","article-title":"Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim","volume":"5","author":"Paschos","year":"2009","journal-title":"PLoS Pathog."},{"key":"B162","doi-asserted-by":"publisher","first-page":"e18270","DOI":"10.7554\/eLife.18270","article-title":"MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs","volume":"5","author":"Wood","year":"2016","journal-title":"Elife"},{"key":"B163","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1021\/cb4006326","article-title":"Identification of a new class of small molecules that efficiently reactivate latent Epstein-Barr Virus","volume":"9","author":"Tikhmyanova","year":"2014","journal-title":"ACS Chem Biol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"e0145994","DOI":"10.1371\/journal.pone.0145994","article-title":"Identification of novel small organic compounds with diverse structures for the induction of Epstein-Barr virus (EBV) lytic cycle in EBV-positive epithelial malignancies","volume":"10","author":"Choi","year":"2015","journal-title":"PLoS ONE"},{"key":"B165","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.3390\/cancers10040089","article-title":"Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas","volume":"10","author":"Ramayanti","year":"2018","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00081\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T17:46:34Z","timestamp":1606585594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00081\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":165,"alternative-id":["10.3389\/fonc.2019.00081"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.00081","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"article-number":"81"}}